The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis by Watson, JA, Commons, RJ, Tarning, J, Simpson, JA, Llanos Cuentas, A, Lacerda, MVG, Green, JA, Koh, GCKW, Chu, CS, Nosten, FH, Price, RN, Day, NPJ, White, NJ

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis' by Watson, JA, Commons, RJ, Tarning, J, Simpson, JA, Llanos Cuentas, A, Lacerda, MVG, Green, JA, Koh, GCKW, Chu, CS, Nosten, FH, Price, RN, Day, NPJ, White, NJ

Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial by Hobbs, FDR, Montgomery, H, Padilla, F, Simón-Campos, JA, Kim, K, Arbetter, D, Padilla, KW, Reddy, VP, Seegobin, S, Streicher, K, Templeton, A, Viani, RM, Johnsson, E, Koh, GCKW, Esser, MT

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria by St Jean, PL, Koh, GCKW, Breton, JJ, Espino, FEJ, Hien, TT, Krudsood, S, Lacerda, MVG, Llanos-Cuentas, A, Lon, C, Mohammed, R, Namaik-Larp, CS, Pereira, DB, Saunders, DL, Velez, ID, Yilma, D, Villegas, MF, Duparc, S, Green, JA

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis by Fadilah, I, Commons, RJ, Chau, NH, Chu, CS, Day, NPJ, Koh, GCKW, Green, JA, Lacerda, MV, Llanos-Cuentas, A, Nelwan, EJ, Nosten, F, Pasaribu, AP, Sutanto, I, Taylor, WRJ, Thriemer, K, Price, RN, White, NJ, Baird, JK, Watson, JA

Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-cont... by Montgomery, H, Hobbs, FDR, Padilla, F, Arbetter, D, Templeton, A, Seegobin, S, Kim, K, Campos, JAS, Arends, RH, Brodek, BH, Brooks, D, Garbes, P, Jimenez, J, Koh, GCKW, Padilla, KW, Streicher, K, Viani, RM, Alagappan, V, Pangalos, MN, Esser, MT, TACKLE Study Group

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites by Siegel, SV, Trimarsanto, H, Amato, R, Murie, K, Taylor, AR, Sutanto, E, Kleinecke, M, Whitton, G, Watson, JA, Imwong, M, Assefa, A, Rahim, AG, Nguyen, HC, Tran, TH, Green, JA, Koh, GCKW, White, NJ, Day, N, Kwiatkowski, DP, Rayner, JC, Price, RN, Auburn, S

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria by Llanos-Cuentas, A, Lacerda, MVG, Hien, TT, Vélez, ID, Namaik-Larp, C, Chu, CS, Villegas, MF, Val, F, Monteiro, WM, Brito, MAM, Costa, MRF, Chuquiyauri, R, Casapía, M, Nguyen, CH, Aruachan, S, Papwijitsil, R, Nosten, FH, Bancone, G, Angus, B, Duparc, S, Craig, G, Rousell, VM, Jones, SW, Hardaker, E, Clover, DD, Kendall, L, Mohamed, K, Koh, GCKW, Wilches, VM, Breton, JJ, Green, JA

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria by Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW